Cargando…
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
Targeting CD47 efficiently enhances macrophage phagocytosis in both physiological and pathological conditions. Anti-CD47 antibodies have been shown to inhibit the progression of several types of cancer. However, the mechanism of anti-CD47 monoclonal antibody (mAb) treatment remains controversial. In...
Autores principales: | Liu, Ran, Wei, Huiting, Gao, Peng, Yu, Hu, Wang, Ke, Fu, Zheng, Ju, Baohui, Zhao, Meng, Dong, Shangwen, Li, Zhijun, He, Yifeng, Huang, Yuting, Yao, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503592/ https://www.ncbi.nlm.nih.gov/pubmed/28380460 http://dx.doi.org/10.18632/oncotarget.16547 |
Ejemplares similares
-
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation
por: Li, Zhiqiang, et al.
Publicado: (2021) -
CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes
por: Zhang, Jing, et al.
Publicado: (2020) -
Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation
por: Suter, Emily C., et al.
Publicado: (2021) -
CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer
por: Gu, Shenglan, et al.
Publicado: (2018) -
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
por: Huang, Wei, et al.
Publicado: (2018)